お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、ペットのワクチンの世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にペットのワクチン市場を分類しています。
本レポートでは世界のペットのワクチン市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Boehringer Ingelheim、Zoetis、Elanco Animal Health、Merck Animal Health、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Meiji、Ouro Fino Saude、Animalcare Group、Parnell、CAHIC、Ringpu、Jinyu Group、Keqian Biology、Kyoritsu Seiyaku

レポートはペットのワクチンの主要生産者を調査し、主要地域や国の消費状況も提供します。ペットのワクチンの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Nasal Administration
    Injection
    Other

用途別の市場セグメント：
    Cat
    Dog
    Other

本レポートの詳細内容
本レポートは、世界のペットのワクチン市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてペットのワクチン市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）のペットのワクチン生産量、成長率、市場シェアを調査している。

二. 消費面では、ペットのワクチンの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーのペットのワクチン売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界のペットのワクチン市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本ペットのワクチンのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：ペットのワクチンのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： ペットのワクチンの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおけるペットのワクチンの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章ペットのワクチンメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：ペットのワクチンの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：ペットのワクチンの主要メーカーの概要を提供し、製品の説明と仕様、ペットのワクチンの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：ペットのワクチンの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Valued at US$ 4122 million in 2024, the global Pet Vaccine market is forecast to reach US$ 6221 million by 2030, at a CAGR of 7.1% during the forecast period.
Pet vaccines are biological preparations designed to stimulate an immune response in pets, protecting them from infectious diseases caused by viruses, bacteria, and other pathogens. These vaccines help prevent severe illnesses such as rabies, distemper, parvovirus, and feline leukemia, reducing mortality rates and improving the overall health of companion animals. Vaccination is a crucial aspect of preventive veterinary care and is commonly administered to dogs, cats, and other domesticated animals based on specific vaccination schedules.
With advancements in veterinary medicine, modern pet vaccines are becoming more effective, safer, and tailored to specific breeds and regional disease risks. Innovations such as recombinant vaccines and mRNA-based vaccines are enhancing immune responses with fewer side effects. As pet ownership rises globally and awareness of animal health increases, the demand for high-quality pet vaccines continues to grow, supporting both public health and animal welfare.
Market Drivers:
The pet vaccine market is primarily driven by the increasing pet ownership worldwide and a growing awareness of animal health and preventive care. As more people adopt pets, the demand for vaccines to protect them from infectious diseases rises, especially with the expansion of the pet care industry. Moreover, advancements in veterinary vaccines, including more effective and safer vaccines, are improving vaccination outcomes and encouraging wider use. Public health initiatives and regulations, such as rabies vaccination requirements, also play a role in fueling market growth. Additionally, rising disposable incomes, particularly in emerging markets, are enabling pet owners to spend more on veterinary care, including vaccinations.
Market Challenges:
One of the major challenges facing the pet vaccine market is the high cost of some vaccines, which can be a barrier to regular vaccination, especially for pet owners in lower-income regions. Furthermore, the increasing complexity of vaccine schedules and the need for specialized veterinary care may slow down adoption rates in some areas. In addition, the emergence of counterfeit or low-quality vaccines poses a significant threat to market growth and animal health. Regulatory barriers and inconsistencies across different regions can also hinder the efficient distribution and accessibility of vaccines, especially in emerging markets with less-developed veterinary infrastructure.
Report Includes
This report presents an overview of global market for Pet Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pet Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pet Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pet Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pet Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pet Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Boehringer Ingelheim, Zoetis, Elanco Animal Health, Merck Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, etc.

Market Segmentation
By Company
    Boehringer Ingelheim
    Zoetis
    Elanco Animal Health
    Merck Animal Health
    Virbac
    Dechra Veterinary Products
    Ceva
    Vetoquinol
    Meiji
    Ouro Fino Saude
    Animalcare Group
    Parnell
    CAHIC
    Ringpu
    Jinyu Group
    Keqian Biology
    Kyoritsu Seiyaku

Segment by Type
    Nasal Administration
    Injection
    Other

Segment by Application
    Cat
    Dog
    Other

Segment by region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pet Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pet Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
 Table 1. Global Pet Vaccine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Major Manufacturers of Nasal Administration
 Table 3. Major Manufacturers of Injection
 Table 4. Major Manufacturers of Other
 Table 5. Global Pet Vaccine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 6. Global Pet Vaccine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 7. Global Revenue by Region (2020-2025) & (US$ Million)
 Table 8. Global Revenue Market Share by Region (2020-2031)
 Table 9. Global Pet Vaccine Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Doses)
 Table 10. Global Pet Vaccine Sales by Region (2020-2031) & (K Doses)
 Table 11. Global Sales Market Share by Region (2020-2031)
 Table 12. Global Pet Vaccine Sales by Manufacturers (2020-2025) & (K Doses)
 Table 13. Global Pet Vaccine Sales Share by Manufacturers (2020-2025)
 Table 14. Global Pet Vaccine Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 15. Global Pet Vaccine Revenue Market Share by Manufacturers (2020-2025)
 Table 16. Global Key Players of Pet Vaccine, Industry Ranking, 2023 VS 2024 VS 2024
 Table 17. Pet Vaccine Price by Manufacturers (2020-2025) & (USD/Dose)
 Table 18. Global Pet Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 19. Global Pet Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Vaccine as of 2024)
 Table 20. Global Key Manufacturers of Pet Vaccine, Manufacturing Base Distribution and Headquarters
 Table 21. Global Key Manufacturers of Pet Vaccine, Product Offered and Application
 Table 22. Global Key Manufacturers of Pet Vaccine, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Pet Vaccine Sales by Type (2020-2025) & (K Doses)
 Table 25. Global Pet Vaccine Sales by Type (2026-2031) & (K Doses)
 Table 26. Global Sales Share by Type (2020-2031)
 Table 27. Global Pet Vaccine Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Pet Vaccine Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Revenue Share by Type (2020-2031)
 Table 30. Pet Vaccine Price by Type (2020-2025) & (USD/Dose)
 Table 31. Global Pet Vaccine Price Forecast by Type (2026-2031) & (USD/Dose)
 Table 32. Global Pet Vaccine Sales by Application (2020-2025) & (K Doses)
 Table 33. Global Pet Vaccine Sales by Application (2026-2031) & (K Doses)
 Table 34. Global Sales Share by Application (2020-2031)
 Table 35. Global Pet Vaccine Revenue by Application (2020-2025) & (US$ Million)
 Table 36. Global Pet Vaccine Revenue by Application (2026-2031) & (US$ Million)
 Table 37. Global Revenue Share by Application (2020-2031)
 Table 38. Pet Vaccine Price by Application (2020-2025) & (USD/Dose)
 Table 39. Global Pet Vaccine Price Forecast by Application (2026-2031) & (USD/Dose)
 Table 40. US & Canada Sales by Type (2020-2031) & (K Doses)
 Table 41. US & Canada Revenue by Type (2020-2031) & (US$ Million)
 Table 42. US & Canada Sales by Application (2020-2031) & (K Doses)
 Table 43. US & Canada Revenue by Application (2020-2031) & (US$ Million)
 Table 44. US & Canada Pet Vaccine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 45. US & Canada Revenue by Country (2020-2031) & (US$ Million)
 Table 46. US & Canada Sales by Country (2020-2031) & (K Doses)
 Table 47. Europe Sales by Type (2020-2031) & (K Doses)
 Table 48. Europe Revenue by Type (2020-2031) & (US$ Million)
 Table 49. Europe Sales by Application (2020-2031) & (K Doses)
 Table 50. Europe Revenue by Application (2020-2031) & (US$ Million)
 Table 51. Europe Pet Vaccine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 52. Europe Sales by Country (2020-2031) & (K Doses)
 Table 53. Europe Revenue by Country (2020-2031) & (US$ Million)
 Table 54. China Sales by Type (2020-2031) & (K Doses)
 Table 55. China Revenue by Type (2020-2031) & (US$ Million)
 Table 56. China Sales by Application (2020-2031) & (K Doses)
 Table 57. China Revenue by Application (2020-2031) & (US$ Million)
 Table 58. Asia Sales by Type (2020-2031) & (K Doses)
 Table 59. Asia Revenue by Type (2020-2031) & (US$ Million)
 Table 60. Asia Sales by Application (2020-2031) & (K Doses)
 Table 61. Asia Revenue by Application (2020-2031) & (US$ Million)
 Table 62. Asia Pet Vaccine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 63. Asia Revenue by Region (2020-2031) & (US$ Million)
 Table 64. Asia Sales by Region (2020-2031) & (K Doses)
 Table 65. Middle East, Africa and Latin America Sales by Type (2020-2031) & (K Doses)
 Table 66. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)
 Table 67. Middle East, Africa and Latin America Sales by Application (2020-2031) & (K Doses)
 Table 68. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)
 Table 69. Middle East, Africa and Latin America Pet Vaccine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 70. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)
 Table 71. Middle East, Africa and Latin America Sales by Country (2020-2031) & (K Doses)
 Table 72. Boehringer Ingelheim Company Information
 Table 73. Boehringer Ingelheim Description and Major Businesses
 Table 74. Boehringer Ingelheim Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 75. Boehringer Ingelheim Product Model Numbers, Pictures, Descriptions and Specifications
 Table 76. Boehringer Ingelheim Recent Developments
 Table 77. Zoetis Company Information
 Table 78. Zoetis Description and Major Businesses
 Table 79. Zoetis Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 80. Zoetis Product Model Numbers, Pictures, Descriptions and Specifications
 Table 81. Zoetis Recent Developments
 Table 82. Elanco Animal Health Company Information
 Table 83. Elanco Animal Health Description and Major Businesses
 Table 84. Elanco Animal Health Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 85. Elanco Animal Health Product Model Numbers, Pictures, Descriptions and Specifications
 Table 86. Elanco Animal Health Recent Developments
 Table 87. Merck Animal Health Company Information
 Table 88. Merck Animal Health Description and Major Businesses
 Table 89. Merck Animal Health Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 90. Merck Animal Health Product Model Numbers, Pictures, Descriptions and Specifications
 Table 91. Merck Animal Health Recent Developments
 Table 92. Virbac Company Information
 Table 93. Virbac Description and Major Businesses
 Table 94. Virbac Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 95. Virbac Product Model Numbers, Pictures, Descriptions and Specifications
 Table 96. Virbac Recent Developments
 Table 97. Dechra Veterinary Products Company Information
 Table 98. Dechra Veterinary Products Description and Major Businesses
 Table 99. Dechra Veterinary Products Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 100. Dechra Veterinary Products Product Model Numbers, Pictures, Descriptions and Specifications
 Table 101. Dechra Veterinary Products Recent Developments
 Table 102. Ceva Company Information
 Table 103. Ceva Description and Major Businesses
 Table 104. Ceva Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 105. Ceva Product Model Numbers, Pictures, Descriptions and Specifications
 Table 106. Ceva Recent Developments
 Table 107. Vetoquinol Company Information
 Table 108. Vetoquinol Description and Major Businesses
 Table 109. Vetoquinol Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 110. Vetoquinol Product Model Numbers, Pictures, Descriptions and Specifications
 Table 111. Vetoquinol Recent Developments
 Table 112. Meiji Company Information
 Table 113. Meiji Description and Major Businesses
 Table 114. Meiji Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 115. Meiji Product Model Numbers, Pictures, Descriptions and Specifications
 Table 116. Meiji Recent Developments
 Table 117. Ouro Fino Saude Company Information
 Table 118. Ouro Fino Saude Description and Major Businesses
 Table 119. Ouro Fino Saude Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 120. Ouro Fino Saude Product Model Numbers, Pictures, Descriptions and Specifications
 Table 121. Ouro Fino Saude Recent Developments
 Table 122. Animalcare Group Company Information
 Table 123. Animalcare Group Description and Major Businesses
 Table 124. Animalcare Group Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 125. Animalcare Group Product Model Numbers, Pictures, Descriptions and Specifications
 Table 126. Animalcare Group Recent Developments
 Table 127. Parnell Company Information
 Table 128. Parnell Description and Major Businesses
 Table 129. Parnell Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 130. Parnell Product Model Numbers, Pictures, Descriptions and Specifications
 Table 131. Parnell Recent Developments
 Table 132. CAHIC Company Information
 Table 133. CAHIC Description and Major Businesses
 Table 134. CAHIC Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 135. CAHIC Product Model Numbers, Pictures, Descriptions and Specifications
 Table 136. CAHIC Recent Developments
 Table 137. Ringpu Company Information
 Table 138. Ringpu Description and Major Businesses
 Table 139. Ringpu Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 140. Ringpu Product Model Numbers, Pictures, Descriptions and Specifications
 Table 141. Ringpu Recent Developments
 Table 142. Jinyu Group Company Information
 Table 143. Jinyu Group Description and Major Businesses
 Table 144. Jinyu Group Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 145. Jinyu Group Product Model Numbers, Pictures, Descriptions and Specifications
 Table 146. Jinyu Group Recent Developments
 Table 147. Keqian Biology Company Information
 Table 148. Keqian Biology Description and Major Businesses
 Table 149. Keqian Biology Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 150. Keqian Biology Product Model Numbers, Pictures, Descriptions and Specifications
 Table 151. Keqian Biology Recent Developments
 Table 152. Kyoritsu Seiyaku Company Information
 Table 153. Kyoritsu Seiyaku Description and Major Businesses
 Table 154. Kyoritsu Seiyaku Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 155. Kyoritsu Seiyaku Product Model Numbers, Pictures, Descriptions and Specifications
 Table 156. Kyoritsu Seiyaku Recent Developments
 Table 157. Key Raw Materials Lists
 Table 158. Raw Materials Key Suppliers Lists
 Table 159. Distributors List
 Table 160. Customers List
 Table 161. Market Trends
 Table 162. Market Drivers
 Table 163. Market Challenges
 Table 164. Market Restraints
 Table 165. Research Programs/Design for This Report
 Table 166. Key Data Information from Secondary Sources
 Table 167. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pet Vaccine Product Picture
 Figure 2. Global Pet Vaccine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Pet Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Nasal Administration Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Pet Vaccine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Global Pet Vaccine Market Share by Application: 2024 & 2031
 Figure 9. Cat
 Figure 10. Dog
 Figure 11. Other
 Figure 12. Pet Vaccine Report Years Considered
 Figure 13. Global Pet Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Pet Vaccine Revenue by Region (2020-2031) (US$ Million)
 Figure 16. Global Pet Vaccine Revenue Market Share by Region in Percentage: 2024 Versus 2031
 Figure 17. Global Pet Vaccine Revenue Market Share by Region (2020-2031)
 Figure 18. Global Pet Vaccine Sales (2020-2031) & (K Doses)
 Figure 19. Global Pet Vaccine Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (K Doses)
 Figure 20. Global Pet Vaccine Sales Market Share by Region (2020-2031)
 Figure 21. US & Canada Pet Vaccine Sales YoY (2020-2031) & (K Doses)
 Figure 22. US & Canada Pet Vaccine Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. Europe Pet Vaccine Sales YoY (2020-2031) & (K Doses)
 Figure 24. Europe Pet Vaccine Revenue YoY (2020-2031) & (US$ Million)
 Figure 25. China Pet Vaccine Sales YoY (2020-2031) & (K Doses)
 Figure 26. China Pet Vaccine Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. Asia (excluding China) Pet Vaccine Sales YoY (2020-2031) & (K Doses)
 Figure 28. Asia (excluding China) Pet Vaccine Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Middle East, Africa and Latin America Pet Vaccine Sales YoY (2020-2031) & (K Doses)
 Figure 30. Middle East, Africa and Latin America Pet Vaccine Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. Global Pet Vaccine Sales Share by Manufacturers (2024)
 Figure 32. The Pet Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
 Figure 33. Global Pet Vaccine Revenue Share by Manufacturers (2024)
 Figure 34. The Top 5 and 10 Largest Manufacturers of Pet Vaccine in the World: Market Share by Pet Vaccine Revenue in 2024
 Figure 35. Global Pet Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 36. Global Pet Vaccine Sales Market Share by Type (2020-2031)
 Figure 37. Global Pet Vaccine Revenue Market Share by Type (2020-2031)
 Figure 38. Global Pet Vaccine Sales Market Share by Application (2020-2031)
 Figure 39. Global Pet Vaccine Revenue Market Share by Application (2020-2031)
 Figure 40. US & Canada Pet Vaccine Sales Market Share by Type (2020-2031)
 Figure 41. US & Canada Pet Vaccine Revenue Market Share by Type (2020-2031)
 Figure 42. US & Canada Pet Vaccine Sales Market Share by Application (2020-2031)
 Figure 43. US & Canada Pet Vaccine Revenue Market Share by Application (2020-2031)
 Figure 44. US & Canada Pet Vaccine Revenue Share by Country (2020-2031)
 Figure 45. US & Canada Pet Vaccine Sales Share by Country (2020-2031)
 Figure 46. US Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 47. Canada Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 48. Europe Pet Vaccine Sales Market Share by Type (2020-2031)
 Figure 49. Europe Pet Vaccine Revenue Market Share by Type (2020-2031)
 Figure 50. Europe Pet Vaccine Sales Market Share by Application (2020-2031)
 Figure 51. Europe Pet Vaccine Revenue Market Share by Application (2020-2031)
 Figure 52. Europe Pet Vaccine Sales Share by Country (2020-2031)
 Figure 53. Europe Pet Vaccine Revenue Share by Country (2020-2031)
 Figure 54. Germany Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 55. France Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 56. U.K. Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 57. Italy Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 58. Russia Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 59. China Pet Vaccine Sales Market Share by Type (2020-2031)
 Figure 60. China Pet Vaccine Revenue Market Share by Type (2020-2031)
 Figure 61. China Pet Vaccine Sales Market Share by Application (2020-2031)
 Figure 62. China Pet Vaccine Revenue Market Share by Application (2020-2031)
 Figure 63. Asia Pet Vaccine Sales Market Share by Type (2020-2031)
 Figure 64. Asia Pet Vaccine Revenue Market Share by Type (2020-2031)
 Figure 65. Asia Pet Vaccine Sales Market Share by Application (2020-2031)
 Figure 66. Asia Pet Vaccine Revenue Market Share by Application (2020-2031)
 Figure 67. Asia Pet Vaccine Revenue Share by Region (2020-2031)
 Figure 68. Asia Pet Vaccine Sales Share by Region (2020-2031)
 Figure 69. Japan Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 70. South Korea Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 71. China Taiwan Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 72. Southeast Asia Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 73. India Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 74. Australia Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 75. Middle East, Africa and Latin America Pet Vaccine Sales Market Share by Type (2020-2031)
 Figure 76. Middle East, Africa and Latin America Pet Vaccine Revenue Market Share by Type (2020-2031)
 Figure 77. Middle East, Africa and Latin America Pet Vaccine Sales Market Share by Application (2020-2031)
 Figure 78. Middle East, Africa and Latin America Pet Vaccine Revenue Market Share by Application (2020-2031)
 Figure 79. Middle East, Africa and Latin America Pet Vaccine Revenue Share by Country (2020-2031)
 Figure 80. Middle East, Africa and Latin America Pet Vaccine Sales Share by Country (2020-2031)
 Figure 81. Brazil Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 82. Mexico Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 83. Turkey Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 84. Israel Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 85. GCC Countries Pet Vaccine Revenue (2020-2031) & (US$ Million)
 Figure 86. Value Chain
 Figure 87. Pet Vaccine Production Process
 Figure 88. Channels of Distribution (Direct Vs Distribution)
 Figure 89. Bottom-up and Top-down Approaches for This Report
 Figure 90. Data Triangulation
 Figure 91. Key Executives Interviewed